Prevention of Lymphorrhea by Means of Fibrin Glue after Axillary Lymphadenectomy in Breast Cancer: Prospective Randomized Trial

1998 ◽  
Vol 30 (6) ◽  
pp. 439-443 ◽  
Author(s):  
F.N. Gilly ◽  
Y. François ◽  
A.C. Sayag-Beaujard ◽  
O. Glehen ◽  
A. Brachet ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Randomized Trial ◽  
Fibrin Glue ◽  
Prospective Randomized Trial ◽  
Axillary Lymphadenectomy

Does the use of fibrin glue prevent seroma formation after axillary lymphadenectomy for breast cancer? A prospective randomized trial in 159 patients

2010 ◽  
Vol 101 (7) ◽  
pp. 600-603 ◽  
Author(s):  
Calogero Cipolla ◽  
Salvatore Fricano ◽  
Salvatore Vieni ◽  
Giuseppa Graceffa ◽  
Gaspare Licari ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Randomized Trial ◽  
Fibrin Glue ◽  
Seroma Formation ◽  
Prospective Randomized Trial ◽  
Axillary Lymphadenectomy

PP-2-11 a prospective randomized trial of short versus long hospital stay after surgery for breast cancer

1996 ◽  
Vol 32 ◽  
pp. 16 ◽  
Author(s):  
J. Bonnema ◽  
A.N. van Geel ◽  
A. van Wersch ◽  
J.F.A. Pruyn ◽  
Th. Wiggers
Keyword(s):  
Breast Cancer ◽  
Hospital Stay ◽  
Randomized Trial ◽  
Prospective Randomized Trial

A prospective randomized trial of ICRF-187 for prevention of cumulative doxorubicin-induced cardiac toxicity in women with breast cancer

1990 ◽  
Vol 17 (2-3) ◽  
pp. 161-163 ◽  
Author(s):  
J.L. Speyer ◽  
M.D. Green ◽  
J. Sanger ◽  
A. Zeleniuch-Jacquotte ◽  
E. Kramer ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Randomized Trial ◽  
Cardiac Toxicity ◽  
Prospective Randomized Trial

Sentinel-Lymphnode Biopsy in primary breast cancer: 99mTc versus ICG—A prospective, randomized trial.

2020 ◽  
Vol 38 (15_suppl) ◽  
pp. 575-575
Author(s):  
Peter Kern ◽  
Ann-Kathrin Bittner ◽  
Oliver Hoffmann ◽  
Rainer Kimmig ◽  
Ariane Schoffer ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Randomized Trial ◽  
Primary Breast Cancer ◽  
Near Infrared ◽  
Reference Method ◽  
Prospective Randomized Trial ◽  
Infrared Light ◽  
Study Cohort ◽  
Preparation Time ◽  
Sentinel Lymphnode Biopsy

575 Background: Sentinel-Lymphnode Biopsy (SLNB) is the standard procedure in primary breast cancer, routinely performed with 99mTechnetium radioactive tracers. Awareness of nuclear waste, costs and time consumption lead to the desire of breast surgeons to find safe and effective alternative options for detection of sentinel lymph nodes (SLN) in breast cancer and melanoma. Indocyaningreen is a tracer which emits fluorescence with near-infrared light of 780-810 nm when injected in the peritumoral or periareolar region, enabling surgeons to detect SLN and lymphatic pathways at the breast. Methods: We performed a prospective, randomized trial with patients with primary breast cancer. Both detection methods have been applied to patients of the study cohort comparing the preparation time, time to identify, concordance of the two methods and costs. Reference method was preoperative lymphszintigraphy. Results: 55 patients have been analyzed in this first report. Preparation time was 75,8 min (range 60-120 min) for 99mTc-tracer and a standard of 20 min for ICG. Time to identify SLN at a mean of 3,8 min(range 1-15 min) for 99mTc and 3 min (range 1-8 min) for ICG. Concordance rates were 98,2 % for the 1st SLN, 93,8 % both for 2nd and 3rd SLN. After neoadjuvant chemotherapy, all SLN have been been detected by both techniques, in 3 patients additional SLN have been found by ICG. Costs have been cut down to 1/10 with the use of ICG, coming up to saving of 27 000 US-$ per each 100 SLNB procedures performed. Conclusions: We report a high concordance rate between the 2 techniques - 99mTechnetium and ICG with near-infrared - for detection of SLN in breast cancer. Preparation time is cut down to less than 30 %, and costs to less the 10 % of radioactive labelling. Clinical trial information: 18-8054-BO .

A prospective randomized trial of high versus low vacuum drainage after axillary dissection for breast cancer

1997 ◽  
Vol 173 (2) ◽  
pp. 76-79 ◽  
Author(s):  
Jorien Bonnema ◽  
Albert N. van Geel ◽  
David A. Ligtenstein ◽  
Paul I.M. Schmitz ◽  
Theo Wiggers
Keyword(s):  
Breast Cancer ◽  
Randomized Trial ◽  
Axillary Dissection ◽  
Prospective Randomized Trial
Sign in / Sign up

Export Citation Format

Share Document